Estrogen receptor-α mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs

Endocrinology

Volumn 150, Issue 2, 2009, Pages 795-802

  Ben Jonathan, Nira ^a   Chen, Shenglin ^b   Dunckley, Joseph A ^a   Lapensee, Christopher ^a   Kansra, Sanjay ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS(4 HYDROXYPHNEYL) 4 METHYL 5 [4 (2 PIPERIDINYLET HPXY)PHENOL] 1H PYRAZOLE HYDROCHLORIDE; 4 [2 PHENYL 5,7 BIS(TRIFLUOROMETHYL) PYRAZOLOL{1,5 A]PYRIMIDIN 3YL]PHENOL; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; HORMONE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION; HORMONE RELEASE; HYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; GENE EXPRESSION REGULATION; LACTOTROPHS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROLACTIN; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS;

EID: 59649112705     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0756     Document Type: Article

References (48)

1. Oda K, Matsuoka Y, Funahashi A, Kitano H 2005 A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1:2005
2. Yarden Y, Sliwkowski MX 2001 Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137
3. White BA, Bancroft FC 1983 Epidermal growth factor and thyrotropin-releasing hormone interact synergistically with calcium to regulate prolactin mRNA levels. J Biol Chem 258:4618-4622
4. Childs GV, Rougeau D, Unabia G 1995 Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes. Endocrinology 136:1595-1602
5. Chabot JG, Walker P, Pelletier G 1986 Distribution of epidermal growth factor binding sites in the adult rat anterior pituitary gland. Peptides 7:45-50
6. Birman P, Michard M, Li JY, Peillon F, Bression D 1987 Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas. J Clin Endocrinol Metab 65:275-281
7. Fan X, Childs GV 1995 Epidermal growth factor and transforming growth factor-a messenger ribonucleic acids and their receptors in the rat anterior pituitary: localization and regulation. Endocrinology 136:2284-2293
8. FanX, NagleGT, Collins TJ, Childs GV1995 Differential regulation of epidermal growth factor and transforming growth factor-α messenger ribonucleic acid in the rat anterior pituitary and hypothalamus induced by stresses. Endocrinology 136:873-880
9. Finley EL, King JS, Ramsdell JS 1994 Human pituitary somatotropes express transforming growth factor-α and its receptor. J Endocrinol 141:547-554
10. Driman DK, Kobrin MS, Kudlow JE, Asa SL 1992 Transforming growth factor-α in normal and neoplastic human endocrine tissues. Hum Pathol 23: 1360-1365
11. Tashjian Jr AH, Yasumura Y, Levine L, Sato GH, Parker ML1968 Establish ment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82:342
12. Missale C, Castelletti L, Boroni F, Memo M, Spano P 1991 Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. Endocrinology 128:13-20
13. Schonbrunn A, Krasnoff M, Westendorf JM, Tashjian Jr AH 1980 Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. J Cell Biol 85:786-797
14. Watters JJ, Chun TY, Kim YN, Bertics PJ, Gorski J 2000 Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol 14:1872-1881
15. Hashi A, Mazawa S, Chen SY, Yamakawa K, Kato J, Arita J 1996 Estradiolinduced diurnal changes in lactotroph proliferation and their hypothalamic regulation in ovariectomized rats. Endocrinology 137:3246-3252
16. Ben-Jonathan N, Lapensee CR, Lapensee EW 2008 What can we learn from rodents about prolactin in humans? Endocr Rev 29:1-41
17. Mitchner NA, Garlick C, Steinmetz RW, Ben-Jonathan N 1999 Differential regulation and action of estrogen receptors α and β in GH3 cells. Endocrinology 140:2651-2658
18. Kansra S, Yamagata S, Sneade L, Foster L, Ben Jonathan N 2005 Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 239:27-36
19. Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG 1997 Role of estrogen receptor-α in the anterior pituitary gland. Mol Endocrinol 11:674-681
20. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95: 15677-15682
21. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494
22. Bunone G, Briand PA, Miksicek RJ, Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183
23. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998
24. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS 1992 Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
25. Vignon F, Bouton MM, Rochefort H 1987 Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502-1508
26. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS 1996 Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93:12626-12630
27. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR 2000 Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660
28. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI 2002 Estrogenaction via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84
29. Nelson KG, Takahashi T, Bossert NL, Walmer DK, McLachlan JA 1991 Epidermal growth factor replaces estrogen in the stimulation of female genitaltract growth and differentiation. Proc Natl Acad Sci USA 88:21-25
30. Razandi M, Pedram A, Park ST, Levin ER 2003 Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712
31. 3 cells by posterior pituitary cells. Endocrinology 135:2737-2741
32. Kumagai T, Davis JG, Horie T, O'Rourke DM, Greene MI 2001 The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling. Proc Natl Acad Sci USA 98:5526-5531
33. Kumagai T, Katsumata M, Hasegawa A, Furuuchi K, Funakoshi T, Kawase I, Greene MI 2003 Role of extracellular subdomains of p185c-neu and the epi dermal growth factor receptor in ligand-independent association and transactivation. Proc Natl Acad Sci USA 100:9220-9225
34. Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI 1994 Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Proc Natl Acad Sci USA 91:1500-1504
35. Riese DJ, Stern DF 1998 Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20:41-48
36. Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y, Hynes NE 1995 Neu differentiation factor activation ofErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol Cell Biol 15:6496-6505
37. Graus-Porta D, Beerli RR, Hynes NE 1995 Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol Cell Biol 15:1182-1191
38. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y 1996 ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15:254-264
39. Wada T, Qian XL, Greene MI 1990 Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339 -1347
40. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, VandlenRL, Carraway III KL 1994 Coexpression oferbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665
41. Ezzat S, Zheng L, Smyth HS, Asa SL 1997 The c-erbB-2/neu proto-oncogene in human pituitary tumours. Clin Endocrinol (Oxf) 46:599-606
42. Chaidarun SS, Eggo MC, Sheppard MC, Stewart PM 1994 Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. Endocrinology 135: 2012-2021
43. Schweppe RE, Frazer-Abel A, Gutierrez-Hartmann A, Bradford AP 1997 Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. J Biol Chem 49:30852-30859
44. Ezzat S 2001 The role of hormones, growth factors and their receptors in pituitary tumorigenesis. Brain Pathol 11:356 -370
45. LeRiche VK, Asa SL, Ezzat S 1996 Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81:656 -662
46. Mueller SG, Kobrin MS, Paterson AJ, Kudlow JE 1989 Transforming growth factor-α expression in the anterior pituitary gland: regulation by epidermal growth factor and phorbol ester in dispersed cells. Mol Endocrinol 3:976 -983
47. Murdoch GH, Potter E, Nicolaisen AK, Evans RM, Rosenfeld MG 1982 Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature 300:192-194
48. Borgundvaag B, KudlowJE, Mueller SG, George SR 1992 Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-α gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130:3453-3458